Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Proponents often emphasize the opportunity for substantial therapeutic gains, principally in conditions where conventional treatments have proven limited. However, crucially important to evaluate the considerable financial expenditure associated with